Invitrogen

PLVAP Polyclonal Antibody

图: 1 / 1

PLVAP Antibody (PA5-110183) in WB

Western blot analysis of PLVAP in extracts of various cell lines. Samples were incubated with PLVAP Polyclonal antibody (Product # PA5-110183) using a dilution of 1:1,000, followed by HRP Goat Anti-Rabbit IgG (H+L) at a dilution of 1:10,000. Lysates/proteins: 25 µg per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.

Product Image Gallery

产品信息

PA5-110183

应用

建议稀释比

已发表文章

免疫印迹 (WB)

1:500-1:2,000

查看1篇已发表文章 1篇已发表文章

产品规格

种属反应

Mouse, Rat

已发表种属

Bovine

宿主/亚型

Rabbit / IgG

分类

Polyclonal

类型

Antibody

抗原

Recombinant fusion protein containing a sequence corresponding to amino acids 63-442 of human PLVAP (NP_112600.1).

查看免疫原

偶联物

Unconjugated Unconjugated Unconjugated

形式

Liquid

浓度

2.67 mg/mL

纯化类型

Affinity Chromatography

保存液

PBS, pH 7.3, with 50% glycerol

内含物

0.01% thimerosal

保存条件

-20° C, Avoid Freeze/Thaw Cycles

运输条件

Wet ice

RRID

AB_2855594

产品详细信息

Immunogen sequence: TERRAEGLYS QLLGLTASQS NLTKELNFTT RAKDAIMQMW LNARRDLDRI NASFRQCQGD RVIYTNNQRY MAAIILSEKQ CRDQFKDMNK SCDALLFMLN QKVKTLEVEI AKEKTICTKD KESVLLNKRV AEEQLVECVK TRELQHQERQ LAKEQLQKVQ ALCLPLDKDK FEMDLRNLWR DSIIPRSLDN LGYNLYHPLG SELASIRRAC DHMPSLMSSK VEELARSLRA DIERVARENS DLQRQKLEAQ QGLRASQEAK QKVEKEAQAR EAKLQAECSR QTQLALEEKA VLRKERDNLA KELEEKKREA EQLRMELAIR NSALDTCIKT KSQPMMPVSR PMGPVPNPQP IDPASLEEFK RKILESQRPP AGIPVAPSSG

靶标信息

PLVAP involved in the formation of stomatal and fenestral diaphragms of caveolae. This protein may function in microvascular permeability.

⚠WARNING: This product can expose you to chemicals including mercury, which is known to the State of California to cause birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

仅用于科研。不用于诊断过程。未经明确授权不得转售。

Product References

Impairment of the Retinal Endothelial Cell Barrier Induced by Long-Term Treatment with VEGF-A₁₆₅ No Longer Depends on the Growth Factor's Presence.

Biomolecules

Deissler HL,Rehak M,Wolf A

PA5-110183 was used in Western Blotting to conclude that several days after the addition of VEGF-A165 to iBREC, barrier dysfunction is mainly sustained by increased paracellular flow and impaired adhesion.